Start the conversation
It was the first stock we recommended on the first day Private Briefing was published.
And that stock hit a new multiyear high today - and is now up 686%.
The company I'm talking about is biotech Galapagos NV (Nasdaq ADR: GLPG). We first recommended shares of the Belgian biotech at $8.60 each back in mid-August 2011. And we've re-recommended it more than a dozen times since then.
This is premium content for Private Briefing subscribers only.